ch.oddb.org
 
Analyses | Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory    
January - February - March - April - May - June - July - August - September - Oktober - November - December | 2002 - 2003 - 2004 - 2005 - 2006 - 2007 - 2008 - 2009 - 2010 - 2011 - 2012 - 2013 - 2014 - 2015 - 2016 - 2017 - 2018 - 2019
April 2019 - 33 products
  IPCI Yescarta68 mlPRPRk.A.Axicabtagenum Ciloleucelum Zelldispersion von 0.4 – 2 X 10e8 Zellen/einzel-Infusionsbeutel (68 Ml)Gilead Sciences
Switzerland Sàrl
AGtell a friend
     Ilumetri 100 mg/1 ml PRPRk.A.Injection solution: Tildrakizumabum 100 mg/mlAlmirall AGBGtell a friend
     Ilumetri 100 mg/1 ml2PRPRk.A.Injection solution: Tildrakizumabum 100 mg/mlAlmirall AGBGtell a friend
     Nutryelt Junior 10 ml10 x 10 mlPRPRk.A.Concentrate for infusion: 5 Active AgentsBaxter AGBGtell a friend
     Otrivin Schnupfen Plus10 mlPRPRk.A.Nasal spray: 2 Active AgentsGSK Consumer
Healthcare Schweiz AG
DGtell a friend
  IP  Biktarvy30PRPRk.A.Coated tablets: 3 Active AgentsGilead Sciences
Switzerland Sàrl
AGtell a friend
     Fluoxetin Axapharm 20 mg30PRPRk.A.Coated tablets: Fluoxetinum 20 mgAxapharm AGBGtell a friend
     Fluoxetin Axapharm 20 mg100PRPRk.A.Coated tablets: Fluoxetinum 20 mgAxapharm AGBGtell a friend
  IP  Imbruvica 140 mg30PRPRk.A.Coated tablets: Ibrutinibum 140 mgJanssen-Cilag AGAGtell a friend
  IP  Imbruvica 280 mg30PRPRk.A.Coated tablets: Ibrutinibum 280 mgJanssen-Cilag AGAGtell a friend
  IP  Imbruvica 420 mg30PRPRk.A.Coated tablets: Ibrutinibum 420 mgJanssen-Cilag AGAGtell a friend
  IP  Imbruvica 560 mg30PRPRk.A.Coated tablets: Ibrutinibum 560 mgJanssen-Cilag AGAGtell a friend
     Olmesartan Amlodipin HCT
Sandoz 20 mg/5 mg/12.5 mg
28PRPRk.A.Coated tablets: 3 Active AgentsSandoz
Pharmaceuticals AG
BGtell a friend
     Olmesartan Amlodipin HCT
Sandoz 20 mg/5 mg/12.5 mg
98PRPRk.A.Coated tablets: 3 Active AgentsSandoz
Pharmaceuticals AG
BGtell a friend
     Olmesartan Amlodipin HCT
Sandoz 40 mg/5 mg/12.5 mg
28PRPRk.A.Coated tablets: 3 Active AgentsSandoz
Pharmaceuticals AG
BGtell a friend
     Olmesartan Amlodipin HCT
Sandoz 40 mg/5 mg/12.5 mg
98PRPRk.A.Coated tablets: 3 Active AgentsSandoz
Pharmaceuticals AG
BGtell a friend
     Olmesartan Amlodipin HCT
Sandoz 40 mg/10 mg/12.5 mg
28PRPRk.A.Coated tablets: 3 Active AgentsSandoz
Pharmaceuticals AG
BGtell a friend
     Olmesartan Amlodipin HCT
Sandoz 40 mg/10 mg/12.5 mg
98PRPRk.A.Coated tablets: 3 Active AgentsSandoz
Pharmaceuticals AG
BGtell a friend
     Olmesartan Amlodipin HCT
Sandoz 40 mg/5 mg/25 mg
28PRPRk.A.Coated tablets: 3 Active AgentsSandoz
Pharmaceuticals AG
BGtell a friend
     Olmesartan Amlodipin HCT
Sandoz 40 mg/5 mg/25 mg
98PRPRk.A.Coated tablets: 3 Active AgentsSandoz
Pharmaceuticals AG
BGtell a friend
     Olmesartan Amlodipin HCT
Sandoz 40 mg/10 mg/25 mg
28PRPRk.A.Coated tablets: 3 Active AgentsSandoz
Pharmaceuticals AG
BGtell a friend
     Olmesartan Amlodipin HCT
Sandoz 40 mg/10 mg/25 mg
98PRPRk.A.Coated tablets: 3 Active AgentsSandoz
Pharmaceuticals AG
BGtell a friend
  IP  Xarelto vascular 2,5 mg10 x 1PRPRk.A.Coated tablets: Rivaroxabanum 2.5 mgBayer (Schweiz) AGBGtell a friend
  IP  Xarelto vascular 2,5 mg56PRPRk.A.Coated tablets: Rivaroxabanum 2.5 mgBayer (Schweiz) AGBGtell a friend
  IP  Xarelto vascular 2,5 mg100PRPRk.A.Coated tablets: Rivaroxabanum 2.5 mgBayer (Schweiz) AGBGtell a friend
  IP  Xarelto vascular 2,5 mg196PRPRk.A.Coated tablets: Rivaroxabanum 2.5 mgBayer (Schweiz) AGBGtell a friend
  IPCI Spiolto Respimat 2.5 mcg / 2.5 mcg PRPRk.A.Lösung zur Inhalation (wiederverwendbar): 2 Active AgentsBoehringer Ingelheim
(Schweiz) GmbH
BGtell a friend
  IPCI Spiolto Respimat 2.5 mcg / 2.5 mcg3PRPRk.A.Lösung zur Inhalation (wiederverwendbar): 2 Active AgentsBoehringer Ingelheim
(Schweiz) GmbH
BGtell a friend
     Trazimera 150 mg PRPRk.A.Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg AGtell a friend
     Trazimera 440 mg PRPRk.A.Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 440 mg AGtell a friend
  IP  Skyrizi 75 mg2PRPRk.A.lnjektionslösung: Risankizumabum 75 mgAbbVie AGBGtell a friend
  IP  Dupixent 300 mg/2 ml2PRPRk.A.solution injectable en seringue préremplie: Dupilumabum 300mg / 2mlSanofi-Aventis
(Suisse) SA
BGtell a friend
  IP  Dupixent 300 mg/2 ml2PRPRk.A.solution injectable en seringue préremplie avec système de sécurité: Dupilumabum 300mg / 2mlSanofi-Aventis
(Suisse) SA
BGtell a friend
 show caption
2019 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home